Is there a relationship between homocysteine and vitiligo? A pilot study

British Journal of Dermatology

Volumn 159, Issue 3, 2008, Pages 720-724

  Shaker, O G ^a   El Tahlawi, S M R ^a  

^a CAIRO UNIVERSITY   (Egypt)

Author keywords

Homocysteine; Vitiligo

Indexed keywords

HOMOCYSTEINE;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; ENZYME IMMUNOASSAY; FAMILY HISTORY; FEMALE; HUMAN; MALE; PATHOGENESIS; PHOTOTHERAPY; PRIORITY JOURNAL; VITILIGO;

ADULT; AGE FACTORS; CASE-CONTROL STUDIES; FEMALE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; SEX FACTORS; SKIN; VITILIGO;

EID: 49749102437     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08712.x     Document Type: Article

References (39)

1. El-Zawahry M. Pigmentary dermatoses. In : Skin Diseases in Arabian Countries. Cairo : French Institute of Oriental Archeology, 1964 55 72.
2. Lerner AB. On the etiology of vitiligo and gray hair. Am J Med 1971 51 : 141 7.
3. 12 in vitiligo: a nutritional approach. Cutis 1992 50 : 39 42.
4. 12 in Korean patients with vitiligo. Yonsei Med J 1999 40 : 195 8.
5. 12 and folic acid in Egyptian patients with vitiligo. Egypt J Derm Androl 2001 21 : 77 80.
6. 12 and folic acid and the importance of sun exposure. Acta Derm Venereol (Stockh) 1997 77 : 460 2.
7. Mudd SH, Levy HL, Skorby LF. Disorders of transsulfuration. In : The Metabolic and Molecular Basis of Inherited Disease (Scriver CR, Beudet AL, Sly WS, Valle D, eds 7th edn. New York : McGraw-Hill, 1995 1279 327.
8. Guttormsen AB, Schneede J, Ueland PM et al. Kinetics of total plasma homocysteine in subjects with hyperhomocysteinemia due to folate or cobalamin deficiency. Am J Clin Nutr 1996 64 : 194 202.
9. 6 status and relation to sulfur amino acid metabolism in neonates. Am J Clin Nutr 2000 72 : 751 7.
10. Brenton DP, Cusworth DC, Dent CE et al. Homocystinuria. Clinical and dietary studies. Q J Med 1966 35 : 325 46.
11. Goth L, Rass P, Pay A. Catalase enzyme mutations and their association with diseases. Mol Diagn 2004 8 : 141 9.
12. Kurbanov Kh, Burobin VA, Berezov TT. Histidase activity of the skin in relation to the state of melanogenesis. Bull Exp Biol Med 1974 78 : 898 900 [abstract].
13. National Committee for Clinical Laboratory Standards. Procedures for Handling and Processing of Blood Specimens: Approved Guidelines. NCCLS publication H18-A. Villanova, PA : NCCLS, 1990 65 74.
14. Ueland PM. Homocysteine species as components of plasma redox thiol status. Clin Chem 1995 41 : 340 2.
15. Boushey CJ, Beresford SAA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 1995 274 : 1049 57.
16. Jimbow K, Chen H, Park JS, Thomas PS. Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo. Br J Dermatol 2001 144 : 55 6.
17. Aksu K, Turgan N, Oksel F et al. Hyperhomocysteinaemia in Behçet's disease. Rheumatology (Oxford) 2001 40 : 687 90.
18. Kayikcioglu M, Aksu K, Hasdemir C et al. Endothelial functions in Behçet's disease. Rheumatol Int 2006 26 : 304 8.
19. Okka M, Ozturk M, Kockar MC et al. Plasma homocysteine level and uveitis in Behçet's disease. Isr Med Assoc J 2002 4 : 931 4.
20. Refsum H, Helland S, Ueland PM. Fasting plasma homocysteine as a sensitive parameter of antifolate effect: a study of psoriasis patients receiving low-dose methotrexate treatment. Clin Pharmacol Ther 1989 46 : 510 20.
21. Vanizor Kural B, Orem A, Cimsit G et al. Plasma homocysteine and its relationships with atherothrombotic markers in psoriatic patients. Clin Chim Acta 2003 332 : 23 30.
22. Domagala TB, Libura M, Gozdecka H et al. Familial hyperhomocysteinemia with early development of atherosclerosis. [In Polish]. Pol Arch Med Wewn 1996 96 : 354 8.
23. Wilcken DE, Wilcken B. B vitamins and homocysteine in cardiovascular disease and aging. Ann N Y Acad Sci 1998 854 : 361 70.
24. Kaplan ED. Association between homocyst(e)ine levels and risk of vascular events. Drugs Today (Barc) 2003 39 : 175 92.
25. Wakkee M, Thio HB, Prens EP et al. Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Atherosclerosis 2007 190 : 1 9.
26. Boeckler P, Grange F, Krzisch S et al. Acral purpura and hyperhomocysteinemia. Ann Dermatol Venereol 2003 130 : 542 5.
27. Karakurt L, Yilmaz E, Serin E et al. Plasma total homocysteine level in mothers of children with clubfoot. J Pediatr Orthop 2003 23 : 658 60.
28. Kim MH, Kim E, Passen EL et al. Cortisol and estradiol: nongenetic factors for hyperhomocyst(e)inemia. Metabolism 1997 46 : 247 9.
29. Hu CP, Shao JM, Yan JT et al. Study on the distribution of serum homocysteine and on multi-stepwise regression analysis of the associated factors in the population of community areas in Wuhan. [In Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi 2004 25 : 945 8.
30. Wang W, Zhao D, Liu J et al. The distribution of serum homocysteine and its associated factors in a population of 1168 subjects in Beijing area. [In Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi 2002 23 : 32 5.
31. Guo MH, Huang JX, Lin RJ et al. The analysis of plasma homocysteine among 1020 residents in community. [In Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi 2006 27 : 721 4.
32. Genest J Jr. Hyperhomocyst(e)inemia - determining factors and treatment. Can J Cardiol 1999 15 (Suppl. B 35 38B.
33. Guilland JC, Favier A, Potier de Courcy G et al. Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease? 1. Basic data. [In French]. Pathol Biol (Paris) 2003 51 : 101 10.
34. Schallreuter KU, Wood JM, Pittelkow MR et al. Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin. Science 1994 263 : 1444 6.
35. Ortonne J-P. Vitiligo and other disorders of hypopigmentation. In : Dermatology (Bolognia JL, Jorizzo JL, Rapini RP, eds). New York : Mosby, 2003 947 73.
36. Brattstrom L, Wilcken DE. Homocysteine and cardiovascular disease: cause or effect? Am J Clin Nutr 2000 72 : 315 23.
37. Reish O, Townsend D, Berry SA et al. Tyrosinase inhibition due to interaction of homocyst(e)ine with copper: the mechanism for reversible hypopigmentation in homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 1995 57 : 127 32.
38. Souto JC, Blanco-Vaca F, Soria JM et al. A genomewide exploration suggests a new candidate gene at chromosome 11q23 as the major determinant of plasma homocysteine levels: results from the GAIT project. Am J Hum Genet 2005 76 : 925 33.
39. Ramakrishnan S, Sulochana KN, Lakshmi S et al. Biochemistry of homocysteine in health and diseases. Indian J Biochem Biophys 2006 43 : 275 83.